![CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression | Scientific Reports CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-50547-9/MediaObjects/41598_2019_50547_Fig1_HTML.png)
CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression | Scientific Reports
![Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer | Oncogene Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2014.136/MediaObjects/41388_2015_Article_BFonc2014136_Fig4_HTML.jpg)
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer | Oncogene
![EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | Nature Reviews Clinical Oncology EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2017.44/MediaObjects/41571_2017_Article_BFnrclinonc201744_Fig1_HTML.jpg)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | Nature Reviews Clinical Oncology
![UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells](https://static-02.hindawi.com/articles/jo/volume-2019/8607859/figures/8607859.fig.006j.jpg)
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells
![Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer | Oncogene Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2014.136/MediaObjects/41388_2015_Article_BFonc2014136_Fig3_HTML.jpg)
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer | Oncogene
![Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects - Hussain - 2021 - Phytotherapy Research - Wiley Online Library Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects - Hussain - 2021 - Phytotherapy Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2970ef10-87b3-44d4-a5c0-952885e8a354/ptr7225-fig-0002-m.jpg)
Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects - Hussain - 2021 - Phytotherapy Research - Wiley Online Library
![Reaction of melarsen oxide with British anti-Lewisite (BAL) to produce... | Download Scientific Diagram Reaction of melarsen oxide with British anti-Lewisite (BAL) to produce... | Download Scientific Diagram](https://www.researchgate.net/publication/41893819/figure/fig8/AS:667210242596881@1536086726554/Reaction-of-melarsen-oxide-with-British-anti-Lewisite-BAL-to-produce-melarsoprol.png)
Reaction of melarsen oxide with British anti-Lewisite (BAL) to produce... | Download Scientific Diagram
![UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells](https://static-02.hindawi.com/articles/jo/volume-2019/8607859/figures/8607859.fig.002a.jpg)
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells
![UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells](https://static-02.hindawi.com/articles/jo/volume-2019/8607859/figures/8607859.fig.004f.jpg)
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells
![Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma - Acharya - 2022 - WIREs Mechanisms of Disease - Wiley Online Library Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma - Acharya - 2022 - WIREs Mechanisms of Disease - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/c1548e25-74cb-4fed-92c4-c6b1bac3d7f5/wsbm1575-toc-0001-m.jpg)
Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma - Acharya - 2022 - WIREs Mechanisms of Disease - Wiley Online Library
![UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells](https://static-02.hindawi.com/articles/jo/volume-2019/8607859/figures/8607859.fig.004i.jpg)
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells
![Plants | Free Full-Text | Anticancer Effects of Propolis Extracts Obtained Using the Cold Separation Method on Breast Cancer Cell Lines Plants | Free Full-Text | Anticancer Effects of Propolis Extracts Obtained Using the Cold Separation Method on Breast Cancer Cell Lines](https://www.mdpi.com/plants/plants-12-00884/article_deploy/html/images/plants-12-00884-g001.png)